The MIT Enterprise Forum of Cambridge often spotlights successful startups and innovative tech companies, and this month it is looking at Covidien, a healthcare company the separated from Tyco in 2007. CEO Richard Meelia will share some strategy behind his company’s growth, and an investor panel focused on the medtech field will follow. The group will discuss acquisitions as an exit strategy. Register here.